China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Efficacy and Safety of Bimekizumab in the Treatment of Moderate to Severe Scalp Psoriasis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130630
Registration Time: 2026/08/22
Type: Interventional study
Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337210
Published by HT Digital Content Services with permission from Health Daily Digest....